Neuraxis Inc./$NRXS
1D1W1MYTD1Y5YMAX
Capital at risk
About Neuraxis Inc.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
- Ticker
- $NRXS
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 24
- Headquarters
- Carmel, United States
- Website
- neuraxis.com
Neuraxis Inc. Metrics
BasicAdvanced
$89M
-
-$0.78
1.47
-
Price and volume
Market cap
$89M
Beta
1.47
52-week high
$9.33
52-week low
$2.21
Average daily volume
131K
Financial strength
Current ratio
3.04
Quick ratio
2.828
Long term debt to equity
0.024
Total debt to equity
0.041
Interest coverage (TTM)
-73.67%
Profitability
EBITDA (TTM)
-7.609
Gross margin (TTM)
85.56%
Net profit margin (TTM)
-144.44%
Operating margin (TTM)
-144.51%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-56.21%
Return on equity (TTM)
-139.76%
Valuation
Price to revenue (TTM)
14.578
Price to book
13.17
Price to tangible book (TTM)
13.69
Price to free cash flow (TTM)
-13.518
Free cash flow yield (TTM)
-7.40%
Free cash flow per share (TTM)
-0.526
Growth
Revenue change (TTM)
65.22%
Earnings per share change (TTM)
-26.28%
3-year revenue growth (CAGR)
25.60%
3-year earnings per share growth (CAGR)
-40.04%
Neuraxis Inc. Financial Performance
Revenues and expenses
Neuraxis Inc. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.